oxford

Why Oxford AstraZeneca's Coronavirus Vaccine Data Has Come Under Scrutiny
The high success rate from one part of the study has come under scrutiny this week. Here's what we know.
By

Why Poor Countries Could Be Priced Out Of A Covid-19 Vaccine
Pharma giant AstraZeneca says it's "too early to comment on pricing post-pandemic".
By
FROM HUFFPOST U.K.